Treatment of ADHD with French maritime pine bark extract, Pycnogenol®

European Child and Adolescent Psychiatry

Volumn 15, Issue 6, 2006, Pages 329-335

  Trebatická, Jana ^a   Kopasová, Soňa ^a   Hradečná, Zuzana ^a   Činovský, Kamil ^a   Škodáček, Igor ^a   Šuba, Ján ^a   Muchová, Jana ^b   Žitňanová, Ingrid ^b   Waczulíková, Iweta ^c   Rohdewald, Peter ^d   Ďuračková, Zdeňka ^b  

^a University Children's Hospital Bratislava   (Slovakia)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^c Physics and Informatics   (Slovakia)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

ADHD; Hyperactivity; Inattention; Pycnogenol

Indexed keywords

PINE CONE EXTRACT; PLACEBO; PYCNOGENOL;

ADOLESCENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERACTIVITY; MALE; MENTAL CONCENTRATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELAPSE; STANDARD; STOMACH DISCOMFORT; SYMPTOM; VISUOMOTOR COORDINATION; WECHSLER INTELLIGENCE SCALE;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DOUBLE-BLIND METHOD; FACULTY; FEMALE; FLAVONOIDS; HUMANS; MALE; OBSERVER VARIATION; PINUS; PLANT BARK; PLANT EXTRACTS; SEVERITY OF ILLNESS INDEX;

EID: 33748101724     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-006-0538-3     Document Type: Article

References (29)

1. Barkley RA (1990) Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment. Guilford Press, New York
2. Biederman J (2005) Attention-deficit/ hyperactivity disorder: a selective overview. Biol Psychiatry 57:1215-1220
3. Buitelaar JK, Danckaerts M, Gillberg C, Zuddas A, Becker K, Bouvard M, Fagan J, Gadoros J, Harpin V, Hazell P, Johnson M, Lerman-Sagie T, Soutullo CA, Wolanczyk T, Zeiner P, Fouche DS, Krikke-Workel J, Zhang S, Michelson D (2004) A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescent with ADHD. Eur Child Adolesc Psychiatry 13:249-257
4. Conners CK, Sitarenios G, Oarker JDA, Epstein JN (1998) The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and Criterion Validity. J Abnorm Child Psychol 26:257-268
5. Dulcan MK, Popper CW (1991) Concise guide to child and adolescent psychiatry. American Psychiatric Press, Washington
6. Ďuračková Z, Muchová J, Sivoň ová M, Chovanová Z, Hauserová M, Blaží ček P, Trebatická J, Rohdewal P (2004) Oxidative stress in pathophysiology of attention deficit hyperactivity disorder and its influence by a polyphenolic natural extracts, pycnogenol. In: Hoikkala A, Soidinsal O, Wähälä K (eds) XXII International Conference on Polyphenols "Polyphenols communications 2004" Helsinki, Finland, 25-28 August 2004. Jyva"skyla, Gummerus Printing, pp 177-178, ISBN 952-10-1977-8
7. Fitzpatrick DF, Bin B, Rohdewald P (1998) Endothelium-dependent vascular effects of Pycnogenol. J Cardiovasc Pharmacol 32:509-515
8. Gillberg C, Gillberg IC, Rasmussen P, Kadesjo B, Soderstrom H, Rasatam M, Johnson M, Rothenberger A, Niklasson L (2004) Co-existing disorders in ADHD - implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 13:180-192
9. Grosse Düweler K, Rohdewald P (2000) Urinary metabolites of French maritime pine bark extract in humans. Pharmazie 55:364-368
10. Hanley JL (1999) Attention deficit disorder. Impact Communications Inc, Green Bay
11. Heimann SW (1999) Pycnogenol® for ADHD? J Am Acad Child Adolesc Psychiatry 38:357-358
12. Ingram DK, Shimada A, Spangler EL, Ikari H, Hengemihle J, Kuo H, Greig N (1996) Cognitive enhancement. New strategies for stimulating cholinergic, glutamatergic, and nitric oxide systems. Ann NY Acad Sci 786:348-361
13. Kaminester DD (1997) Attention Deficit Hyperactivity Disorder and methylphenidate: when society misunderstands medicine. McGill J Med 3:105-114
14. Kubička L, Bursik R, Jirásek J (1973) PDW - Prague child Wechsler. Psychodiagnostic and didactic tests, Bratislava (in Slovak)
15. Liu F, Zhang Y, Lau BHS (1999) Pycnogenol® improves learning impairment and memory deficit in senescence-accelerated mice. J Anti Aging Med 2:349-355
16. Malá E (2000) Hyperkinetické poruchy (F90) In: Hort V, Hrdlic.ka M, Kocourková J, Malá E (eds) Dětská a adolescentní psychiatrie. Portál, Praha pp 307-314
17. Masao H (2000) Pycnogenol®'s therapeutic effect in improving ADHD symptoms in children. Mainichi Shimbun, Oct. 21
18. Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T (2001) Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 108:E83
19. Packer L, Rimbach G, Virgili F (1999) Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, Pycnogenol. Free Rad Biol Med 27:704-724
20. Paclt I, Florian J (1998) Dotazník pro rodiće (CPQ-Conners instrukce). In: Paclt I, Florian J Psychofarmakoterapie dětského a dorostového věku. Praha, Grada Publishing, pp 296-303 (in Slovak)
21. Passwater RA (1998) All about Pycnogenol®. Avery Publishing Group, New York
22. Pogun S, Kuhar MJ (1994) Regulation of neurotransmitter reuptake by nitric oxide. Ann NY Acad Sci 738:305-315
23. Rohdewald PJ (2005) Pycnogenol®, French maritime pine bark extract In: Coates PM, Blackman MR, Cragg G, Levine M, Moss J, White J (eds) Encyclopedia of dietary supplements. Marcel Dekker, New York, pp 545-553, ISBN 0-8247-5504-9
24. Schmidt HW, Walter U (1994) NO at work. Cell 78:919-925
25. Stanislavov R, Nikolova V (2005) Prelox® Plus testosterone for achieving fertilization in previously infertile men. Eur Bull Drug Res 13: 7-13
26. Stough C, Ryan J, Croft K (2004) Antioxidants to ameliorate normal cognitive deterioration due to age. Presented at the International Conference On Healthy Ageing and Longevity. Sydney, Australia, March 5-7, 2004
27. Tenenbaum S, Paull JC, Sparrow EC, Dodd DK, Green L (2002) An experimental comparison of Pycnogenol® and methylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD). J Atten Disord 6:49-60
28. Trebatická J, Škodáček I, Šuba J, Kopasová S, Hradečná Z, Činovský K, Rohdewald P, Ďuračková Z (2004) Treatment success of ADHD by Pycnogenol®. In: Hoikkala A, Soidinsal O, Wähälä K (eds) XXII International Conference on Polyphenols "Polyphenols communications 2004" Helsinki, Finland, 25-28 August 2004. Jyväskyla, Gummerus Printing, pp 179-180, ISBN 952-10-1977-8
29. Yamada K, Noda Y, Nakayama S, Komori Y, Sugihara H, Hasegawa T, Nabeshima T (1995) Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br J Pharmacol 115:852-858